Posted by Michael Wonder on 06 Mar 2023
Sooma Medical receives FDA breakthrough device designation for its innovative at home depression treatment device
6 March 2023 - Sooma Medical has been granted breakthrough device designation by the US FDA for its portable, patient-administered neuromodulation device to treat depression.
This revolutionary treatment utilises a mild electrical current to stimulate targeted brain areas, significantly improving depressive symptoms.
